Ocular Therapeutix (OCUL) Non-Current Assets (2013 - 2026)

Ocular Therapeutix's Non-Current Assets history runs 14 years deep, the most recent figure standing at $26.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 45.58% year-over-year to $26.5 million in Q1 2026; TTM through Mar 2026 was $94.3 million, a 32.78% increase from a year earlier, with the FY2025 full-year figure at $25.9 million, up 52.99% from the prior year.
• Non-Current Assets advanced to $26.5 million in Q1 2026 per OCUL's latest filing, from $25.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $26.5 million in Q1 2026 and bottomed at $12.7 million in Q2 2022.
• The 5-year median for Non-Current Assets is $19.1 million (2024), against an average of $19.2 million.
• Across the five-year window, Non-Current Assets soared 71.35% in 2023 and retreated 17.84% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $19.7 million in 2022, then grew by 0.83% to $19.8 million in 2023, then slipped by 14.51% to $16.9 million in 2024, then surged by 52.99% to $25.9 million in 2025, then grew by 2.34% to $26.5 million in 2026.
• Per Business Quant, the three latest OCUL Non-Current Assets figures stand at $26.5 million (Q1 2026), $25.9 million (Q4 2025), and $23.9 million (Q3 2025).